Abaloparatide for Risk Reduction of Nonvertebral and Vertebral Fractures in Postmenopausal Women with Osteoporosis: A Network Meta-Analysis

被引：0
|
作者：
Reginster, Jean Yves [1 ]
Bianic, Florence [2 ]
Campbell, Rosanne [2 ]
Martin, Monique [2 ]
Williams, Setareh A. [3 ]
Fitzpatrick, Lorraine A. [3 ]
机构：
[1] Univ Liege, Liege, Belgium
[2] inVentiv Hlth, London, England
[3] Radius Hlth Inc, Waltham, MA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2018年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2308
引用
收藏
页数：2
相关论文
共 50 条
  • [1] ABALOPARATIDE FOR RISK REDUCTION OF NONVERTEBRAL AND VERTEBRAL FRACTURES IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: A NETWORK META-ANALYSIS
    Reginster, J.
    Bianic, F.
    Campbell, R.
    Martin, M.
    Williams, S.
    Fitzpatrick, L.
    VALUE IN HEALTH, 2017, 20 (09) : A527 - A527
  • [2] Abaloparatide for risk reduction of nonvertebral and vertebral fractures in postmenopausal women with osteoporosis: a network meta-analysis
    J. -Y. Reginster
    F. Bianic
    R. Campbell
    M. Martin
    S. A. Williams
    L. A. Fitzpatrick
    Osteoporosis International, 2019, 30 : 1465 - 1473
  • [3] Abaloparatide for risk reduction of nonvertebral and vertebral fractures in postmenopausal women with osteoporosis: a network meta-analysis
    Reginster, J. -Y.
    Bianic, F.
    Campbell, R.
    Martin, M.
    Williams, S. A.
    Fitzpatrick, L. A.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 (07) : 1465 - 1473
  • [4] ABALOPARATIDE FOR RISK REDUCTION OF NONVERTEBRAL AND VERTEBRAL FRACTURES IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: AN UPDATED NETWORK META-ANALYSIS
    Reginster, J. -Y.
    Bianic, F.
    Campbell, R.
    Martin, M.
    Williams, S. A.
    Fitzpatrick, L. A.
    OSTEOPOROSIS INTERNATIONAL, 2018, 29 : S49 - S49
  • [5] Teriparatide and the risk of nonvertebral fractures in women with postmenopausal osteoporosis
    Krege, J. H.
    Wan, X.
    BONE, 2012, 50 (01) : 161 - 164
  • [6] Bazedoxifene versus Oral Bisphosphonates for the Prevention of Nonvertebral Fractures in Postmenopausal Women with Osteoporosis at Higher Risk of Fracture: A Network Meta-Analysis
    Ellis, Alexandra G.
    Reginster, Jean-Yves
    Luo, Xuemei
    Cappelleri, Joseph C.
    Chines, Arkadi
    Sutradhar, Santosh
    Jansen, Jeroen P.
    VALUE IN HEALTH, 2014, 17 (04) : 424 - 432
  • [7] The Efficacy of Bisphosphonates in the Prevention of Vertebral, Hip, and Nonvertebral-Nonhip Fractures in Osteoporosis: A Network Meta-Analysis
    Jansen, Jeroen P.
    Bergman, Gert J. D.
    Huels, Jasper
    Olson, Melvin
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2011, 40 (04) : 275 - 284
  • [8] Vertebral fracture risk reduction with risedronate in postmenopausal women with osteoporosis: A meta-analysis of individual patient data
    Adachi, JD
    Li, Z
    Meredith, M
    Chesnut, CH
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S61 - S61
  • [9] Effect of abaloparatide on vertebral, nonvertebral, major osteoporotic, and clinical fractures in a subset of postmenopausal women at increased risk of fracture by FRAX probability
    McCloskey, E. V.
    Fitzpatrick, L. A.
    Hu, M. -Y.
    Williams, G.
    Kanis, J. A.
    ARCHIVES OF OSTEOPOROSIS, 2019, 14 (01)
  • [10] Risedronate rapidly reduces the risk for nonvertebral fractures in women with postmenopausal osteoporosis
    Harrington, JT
    Ste-Marie, LG
    Brandi, ML
    Civitelli, R
    Fardellone, P
    Grauer, A
    Barton, I
    Boonen, S
    CALCIFIED TISSUE INTERNATIONAL, 2004, 74 (02) : 129 - 135
12345